logo
Rapid Review Quiz: Chocolate and Health

Rapid Review Quiz: Chocolate and Health

Medscape6 days ago

Cocoa, the core ingredient in chocolate, has gained attention not only for its flavor, but also for its health benefits. As a rich source of dietary polyphenols, cocoa is being studied for its role in supporting cardiovascular health through antioxidant, anti-inflammatory, and vascular effects. Ongoing research has explored its impact on cardiometabolic risk markers, endothelial function, and various cardiovascular outcomes. Cocoa-based products also provide essential nutrients and bioactive compounds that might influence metabolic and vascular health in complex ways. With large, randomized trials and mechanistic studies continuing to explore these associations, healthcare professionals are increasingly interested in the implications for dietary guidance and prevention strategies.
Do you know the latest research on cocoa and its health benefits? Test yourself with this short quiz.
Results from the large randomized trial COcoa Supplement and Multivitamin Outcomes Study showed that after 3.6 years of follow up, cocoa extract (500 mg flavanols/d, including 80 mg (–)[-]-epicatechin) consumption was associated with a 10% lower rate of total cardiovascular events in older adults, including myocardial infarction, stroke, revascularization, and unstable angina, though this reduction was not statistically significant. However, cocoa supplementation led to a statistically significant 27% reduction in cardiovascular disease death. Among participants who consistently adhered to the supplementation, there was a significant 16% reduction in major cardiovascular events compared with the placebo group.
Learn more about cardiovascular disease.
Dark chocolate consumption, when combined with physical activity, can benefit endothelial function primarily by improving nitric oxide. This effect is largely due to flavanols, compounds in dark chocolate that help relax blood vessels and enhance vascular responsiveness. This leads to improved oxygen delivery and reduced oxidative stress, both essential for maintaining healthy endothelial function.
Although the antioxidant effects of polyphenols might reduce oxidative stress, limited direct evidence supports that dark chocolate significantly reduces plaque formation. Though dark chocolate can influence heart rate variability, this reflects autonomic balance rather than direct heart rate stabilization. Even though some metabolic benefits exist, the most immediate and well-supported vascular benefit of dark chocolate is its enhancement of nitric oxide production and not insulin regulation.
Learn more about plaque formation/atherosclerosis.
Cocoa (the main ingredient in chocolate) is especially rich in magnesium, making chocolate a notable dietary source. Magnesium stands out for its key role in regulating both blood sugar and blood pressure. It supports normal muscle and nerve function, helps maintain a steady heartbeat, and plays a role in glucose metabolism.
Sodium is not abundant in chocolate and is more commonly associated with increased, rather than regulated, blood pressure when consumed in excess. Zinc is present in small amounts and plays a greater role in immune and enzymatic functions than in glucose or blood pressure regulation. Iron is found in modest amounts and is primarily involved in oxygen transport rather than metabolic or cardiovascular control.
Learn more about magnesium.
Regular cocoa consumption has been associated with modest reductions in total cholesterol, likely due to flavonoids. These compounds might reduce cholesterol absorption and LDL production. The effect appears more pronounced in individuals with existing health conditions, supporting cardiovascular health.
Cocoa has not consistently been shown to lower triglycerides, likely because it lacks components like reduced sugar and alcohol, which more directly influence triglyceride levels. Although cocoa might modestly lower LDL, increases in HDL cholesterol have not been reliably reported, as it lacks specific fats that typically raise HDL.
Learn more about LDL cholesterol.
Oleic acid, a monounsaturated fat found in chocolate, has been linked to heart health benefits. It might help protect blood vessels and reduce cardiovascular risk by modulating harmful cellular processes and supporting normal platelet function.
Palmitic acid and stearic acid (saturated fats also present in cocoa) do not offer the same protection. Palmitic acid is associated with adverse effects on heart cell membranes, whereas stearic acid has a neutral impact on cholesterol and no clear cardiovascular benefit. Margaric acid, another saturated fat, is found in much smaller amounts and lacks strong evidence of any heart-protective role.
Learn more about platelet disorders.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr. taps allies and COVID vaccine critics among picks for CDC advisory panel. Here's who's on the list.
RFK Jr. taps allies and COVID vaccine critics among picks for CDC advisory panel. Here's who's on the list.

CBS News

time14 minutes ago

  • CBS News

RFK Jr. taps allies and COVID vaccine critics among picks for CDC advisory panel. Here's who's on the list.

Health and Human Services Robert F. Kennedy Jr. announced Wednesday he's naming eight new advisers to serve on the Centers for Disease Control and Prevention's vaccine recommendations committee, after firing the committee's entire previous roster of 17 advisers. "All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense. They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations," Kennedy said Wednesday in a post on X. Kennedy's picks circumvented the usual CDC process for selecting members of the Advisory Committee on Immunization Practices. In previous administrations, career agency officials — not political leaders — vetted potential experts before forwarding them to the department for the secretary's approval. The panel's influential recommendations are closely watched because they are directly tied to federal policies, like which vaccines insurers are required to cover. The picks announced by Kennedy include some close allies of the secretary and his inner circle. One of them, Dr. Robert Malone, worked on early research related to mRNA vaccine technology but was accused during the COVID-19 pandemic of spreading misinformation about the mRNA vaccines. He was with Kennedy and President Trump at the Trump election night celebration in Florida. "On the basis of data from all over the world, approximately three years ago it was my impression that the risk/benefit ratio of these products did not merit continued use in any cohort," Malone posted last month on his Substack about the mRNA COVID vaccines. Like Kennedy, Malone has questioned the benefits of measles vaccines during the recent record outbreak in Texas, which killed two children, and he has promoted unproven treatments for the virus. Another member picked by Kennedy is Dr. Martin Kulldorff, an epidemiologist who co-authored the pandemic-era Great Barrington Declaration criticizing COVID-19 restrictions, along with now-NIH Director Dr. Jay Bhattacharya. Bhattacharya has described Kulldorff as a close friend. Kulldorff previously worked with the CDC's outside vaccine advisers, before authoring an opinion piece in 2021 criticizing the agency's decision to pause use of Johnson & Johnson's COVID-19 vaccine over safety concerns. He claimed he was fired from working with the committee over the opinion piece. Kulldorff later claimed he was fired from Harvard University for criticizing COVID-19 vaccine requirements. Dr. Cody Meissner, a pediatrics professor who previously served as a member of the Food and Drug Administration's own vaccines panel — the Vaccines and Related Biological Products Advisory Committee – was also named to the committee. Meissner opposed COVID-19 vaccine requirements for children. He also co-authored an opinion piece with now-FDA Commissioner Dr. Marty Makary speaking out against masking of children during the pandemic. Another former member of the FDA vaccines panel who was picked by Kennedy is Vicky Pebsworth, a regional director of the National Association of Catholic Nurses. Pebsworth spoke at a 2020 meeting of the FDA vaccines committee, where she identified herself as the research director for the National Vaccine Information Center and "mother of a child injured by his 15-month well-baby shots in 1998." She said the center's position was that any "coercion and sanctions to persuade adults to take an experimental vaccine, or give it to their children, is unethical and unlawful." Kennedy also praised another pick, MIT professor Retsef Levi, saying: "Dr. Levi has collaborated with public health agencies to evaluate vaccine safety, including co-authoring studies on mRNA COVID-19 vaccines and their association with cardiovascular risks." Levi previously called for more detailed data from the COVID-19 vaccine trials, suggesting that changes to how Pfizer's shot was produced may have caused side effects. But Levi faced criticism for a paper co-authored with Florida Surgeon General Dr. Joseph Ladapo, which was cited in the state's move to recommend that young men not get mRNA COVID-19 vaccines. Experts condemned the paper for misleading methods that could inflate the risk. The views on vaccines of several of Kennedy's other picks are less clear. Kennedy said Dr. Michael A. Ross "contributed to national strategies for cancer prevention and early detection, including those involving HPV immunization," working with the CDC's breast and cervical cancer committee. Ross is described by Kennedy as an obstetrics and gynecology professor at George Washington University and Virginia Commonwealth University, though his name does not appear on directories for either university. Spokespeople for the two institutions did not immediately respond to a request for comment. Dr. James Pagano, described by Kennedy as a "strong advocate for evidence-based medicine," appears to have published little about vaccines or medicine. Records from the Medical Board of California list Pagano as being retired. Another Kennedy pick, Dr. Joseph Hibbeln, retired from the National Institutes of Health in 2020. His research portfolio previously covered nutritional intake of fatty acids like omega-3. Kennedy described him as bringing "expertise in immune-related outcomes, psychiatric conditions, and evidence-based public health strategies."

Cook County jury awards $20.5 million to family of girl who died from toxic levels of morphine
Cook County jury awards $20.5 million to family of girl who died from toxic levels of morphine

CBS News

time41 minutes ago

  • CBS News

Cook County jury awards $20.5 million to family of girl who died from toxic levels of morphine

A Cook County jury awarded more than $20 million in damages to the family of an 11-year-old girl who died from toxic levels of morphine. In October 2020, Ava Wilson was recovering from leukemia when she went for a follow-up appointment at Advocate Children's Hospital. During her appointment, she was crying from pain, and had difficulty walking, according to her family's attorneys. Lab tests revealed she had low platelet counts, low blood cell counts, high liver enzymes, and low blood pressure. She was discharged from Advocate Children's Hospital with instructions to take 15 milligrams of morphine every four hours, triple the amount of her previous prescriptions. A nurse practitioner also increased her gabapentin prescription. Approximately 36 hours after getting home, she died in her sleep from acute drug toxicity of several substances, including lethal levels of morphine in her system at the time of her death. Her family's attorneys said the hospital should have admitted Ava to the hospital to get her blood pressure under control and treat the cause of her pain, but simply sent her home with excessive pain medications. "Ava's body was yelling out to these clinicians, 'help me!', and they just ignored it," attorney Matthew Williams said. After a civil trial, a jury awarded her family $20.5 million in damages. "While nothing will ease the depth of Ava's loved ones' pain, the family appreciates that the jury recognized that Ava's death was preventable and that she should still be with them today," attorney Aaron Boeder said.

Fast Five Quiz: Late-Onset Pompe Disease
Fast Five Quiz: Late-Onset Pompe Disease

Medscape

time42 minutes ago

  • Medscape

Fast Five Quiz: Late-Onset Pompe Disease

Multiple genetic variants have been associated with LOPD. However, the c.-32-13T>G splice site variant is found in up to 90% of adults and 50% of pediatric patients. Patients with LOPD often have compound heterozygous genotypes, with one allele carrying the common c.-32-13T>G splice-site variant and the other harboring a more deleterious GAA mutation (eg, nonsense, frameshift, or large deletion). Other variants— such as and c.1935C>A — are more commonly seen in infantile forms of Pompe disease. Learn more about the pathophysiology of LOPD. Diagnosis of LOPD typically follows a two-step approach: first, measuring GAA enzyme activity (often via dried blood spot assay) followed by confirmatory molecular genetic testing to identify pathogenic GAA variants. Although once considered a first-line diagnostic tool for LOPD, muscle biopsy is no longer preferred due to its invasive nature and the non-specificity of histologic findings. Muscle biopsy may still be considered in rare, ambiguous cases when enzyme and genetic testing are inconclusive or conflicting. CK levels might be elevated in some patients but are nonspecific and primarily serve to raise clinical suspicion. Learn more about the workup for LOPD. Enzyme replacement therapy (ERT) has significantly changed the natural history of the disease by improving survival and stabilizing motor and respiratory function. However, key limitations in skeletal muscle uptake and variability in clinical response remain. This is due to low expression of the mannose-6-phosphate receptor in muscle tissue, which hampers enzyme internalization. As a result, patients might experience a limited or plateaued response. Newer approaches, including modified ERT and gene therapy, are being developed to address this issue. High toxicity to cardiac muscle, uniform patient response, and development of cardiac hypertrophy have not been reported as key limitations. Learn more about treatment options for LOPD. NBS programs have reshaped the understanding of Pompe disease, particularly LOPD. A significant proportion of screen-positive newborns harbor genetic variants associated with LOPD, including pseudo deficiency alleles and variants of uncertain significance. These individuals are often asymptomatic at birth and might not develop symptoms for years, if at all. This has raised important clinical questions around monitoring, counseling, and when (or whether) to initiate therapy; expanded screening has also revealed that the true prevalence of LOPD might be higher than historical estimates suggested. Learn more about the management of LOPD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: UCSF/Science Source

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store